In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on ...

Hanmi Pharmaceutical collaborates with Merck (MSD) to evaluate the combination therapy of its immune anticancer drug candidate and MSD's immune anticancer drug "Keytruda" (ingredient name ...

Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields. Merck KGaA (Merck), headquartered in Darmstadt, Germany, and Israel ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

"I must say it's always impressive to come back to China and witness its significant and rapid transformation happening over time," said Marc Horn, EVP of Merck Group and president of Merck China ...

and is supported in part by Eli Lilly and Company and Merck (known as MSD outside of the US and Canada), including through Cooperative Research and Development Agreements between NCI, SWOG ...

Jefferies analyst Akash Tewari notes that new Medicare Part B & D draft guidance has been released and that Merck (MRK) and Bristol Myers (BMY) are trading down due to updated language on single ...

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times ...

Have you ever wondered if that hypnotic bouncing and color-changing DVD logo has ever hit a corner? The answer is yes, it has, but the answer is complicated. The Lost Math Lessons blog did the ...